ARTERRA BIOSCIENCE
Milan Stock Exchange ARBS.MI
ARTERRA BIOSCIENCE Shareholders' Equity for the year ending December 31, 2023: USD 11.87 M
ARTERRA BIOSCIENCE Shareholders' Equity is USD 11.87 M for the year ending December 31, 2023, a 5.97% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
ARTERRA BIOSCIENCE Shareholders' Equity for the year ending December 31, 2022 was USD 11.20 M, a 3.85% change year over year.
-
ARTERRA BIOSCIENCE Shareholders' Equity for the year ending December 31, 2021 was USD 10.78 M, a 7.90% change year over year.
-
ARTERRA BIOSCIENCE Shareholders' Equity for the year ending December 31, 2020 was USD 9.99 M, a 25.24% change year over year.
-
ARTERRA BIOSCIENCE Shareholders' Equity for the year ending December 31, 2019 was USD 7.98 M, a 172.39% change year over year.
Key data
| Date | Shareholders' Equity | Minority Interest | Total Equity | Total Stockholders Equity and Liabilities |
|---|
Market news
Loading...
Milan Stock Exchange: ARBS.MI
| CEO | Ms. Maria Gabriella Colucci |
| IPO Date | Oct. 28, 2019 |
| Location | Italy |
| Headquarters | via Benedetto Brin, 69 Napoli, 80142Italy |
| Employees | 34 |
| Sector | Health Care |
| Industries | |
Description
Arterra Bioscience S.p.A., a research-based biotech company, engages in the research and development of various ingredients and natural solutions. It develops technological platforms, extraction processes, and raw materials for use in the cosmetics, agriculture, and nutraceutics sectors. Arterra Bioscience S.p.A. was founded in 2003 and is based in Naples, Italy.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email